Viet Nam has strengthened its pandemic preparedness systems over more than a decade through sustained technical and financial support from the World Health Organization, positioning itself as an increasingly active contributor to regional and global health security efforts, according to a feature report published on April 17.

Central to this progress has been the implementation of the Pandemic Influenza Preparedness Framework Partnership Contribution, which since 2013 has supported the development of coordinated national planning mechanisms.

Vietnamese health authorities have established and continuously updated the Pandemic Influenza Preparedness and Response Plan, alongside a national vaccine deployment strategy, creating a structured framework for emergency response.

Although initially designed to address influenza outbreaks, the preparedness plan provided the operational backbone for Viet Nam’s response to the COVID-19 pandemic. Authorities revised the framework in 2023 to incorporate lessons learned from that crisis, further aligning it with evolving public health risks.

Laboratory capacity has also expanded significantly under the programme. Four regional laboratory institutes, including two National Influenza Centres, have enhanced capabilities in viral isolation, molecular diagnostics and genomic sequencing.

These investments enabled rapid adaptation during the COVID-19 pandemic, when laboratory networks were repurposed to support SARS-CoV-2 testing and variant tracking.Officials from the National Influenza Centres said the strengthened systems improved both domestic response capacity and Viet Nam’s contribution to global surveillance efforts.

Laboratory data generated through these facilities has supported international monitoring of respiratory viruses and informed public health decision-making.Surveillance systems have been reinforced through improvements in monitoring influenza-like illness and severe acute respiratory infections.

Enhanced data quality, reporting mechanisms and coordination across institutions have allowed earlier detection of unusual respiratory disease clusters.The system integrates multiple levels of the health sector, including the National Institute of Hygiene and Epidemiology, Pasteur Institutes, provincial Centers for Disease Control, hospitals and laboratories.

This network feeds into global platforms such as the Global Influenza Surveillance and Response System and WHO’s RespiMart data-sharing platform.Authorities have moved to institutionalize integrated surveillance covering influenza, SARS-CoV-2 and other respiratory pathogens under the 2026–2035 National Target Programme on Healthcare, Population and Development.

The initiative aims to strengthen early warning capabilities by linking community-level data, clinical reporting and laboratory analysis into a unified system.Viet Nam has also expanded its capacity to assess zoonotic disease risks.

The country adopted the Joint Risk Assessment tool in 2019, enabling coordinated evaluation of health threats across animal and human sectors. In 2024, this mechanism supported responses to two avian influenza incidents, demonstrating cross-ministerial coordination and rapid decision-making.Health officials say these measures reflect a broader effort to integrate public health preparedness into national development planning.

Investments in health security have accompanied Viet Nam’s wider socio-economic growth, with authorities emphasizing the importance of sustained international cooperation.Dr Vo Hai Son, Deputy Director General of the Viet Nam Administration of Disease Prevention, said the country’s progress has been supported in part by long-term collaboration with WHO under the preparedness framework.

He noted that continued engagement with global partners remains essential to maintaining and expanding system capacity.The WHO report highlights Viet Nam’s role in contributing to regional preparedness by sharing surveillance data, strengthening laboratory networks and participating in global health initiatives.

These efforts are expected to support collective responses to future pandemics and emerging infectious diseases.The report indicates that Viet Nam’s preparedness system is now more interconnected and responsive, with improved capacity to detect, assess and respond to public health threats.

Ongoing collaboration with international partners is expected to further enhance these capabilities as the country continues to invest in health system resilience.

The World Health Organization (WHO) says countries across the Eastern Mediterranean are steadily strengthening systems to detect and respond to respiratory diseases, even as conflict, displacement and political instability continue to strain public health infrastructure.

In a feature released on April 17, WHO described the Eastern Mediterranean Region (EMR) as one of the most complex operating environments for infectious disease preparedness. The region comprises 22 countries and more than 700 million people, with frequent outbreaks ranging from seasonal influenza to zoonotic infections and other respiratory illnesses with epidemic potential.

WHO data show that more than half of these countries are affected by prolonged crises, including armed conflict and humanitarian emergencies, resulting in large-scale population displacement that complicates surveillance and service delivery.The region’s geographic position along major migratory bird pathways and international travel corridors gives it added importance in global influenza monitoring.

Viruses detected in EMR countries are routinely shared with international networks, contributing to global risk assessments and informing seasonal vaccine composition through the WHO-led Global Influenza Surveillance and Response System.WHO attributes much of the region’s progress to the implementation of the Pandemic Influenza Preparedness Framework, adopted in 2011 to improve global readiness for influenza pandemics.

At the time of its introduction, surveillance coverage and laboratory capacity across the EMR varied significantly, and most countries lacked formal vaccination policies. Through the framework’s Partnership Contribution funding mechanism, 11 countries, including Afghanistan, Iran, Iraq and Egypt, received sustained financial and technical support to develop core capacities, while additional countries benefited indirectly.

By 2025, WHO reports that 18 of the 22 EMR countries were regularly submitting influenza data to regional and global platforms, including EMFLU-2, FluNet and FluID. These systems are supported by an expanding network of sentinel surveillance sites that provide epidemiological data.

At the same time, 18 countries had established functioning National Influenza Centres, with at least 14 routinely sharing virus samples with WHO collaborating centres under GISRS.Despite operational challenges linked to insecurity and resource limitations, WHO said laboratory and surveillance functions remained active across most of the region.

This continuity was tested during the COVID-19 pandemic, when countries adapted existing influenza systems to incorporate SARS-CoV-2 testing. WHO described this transition as a catalyst for broader integration, accelerating the shift from single-disease monitoring to multi-pathogen surveillance.

According to WHO, 21 EMR countries now operate integrated sentinel surveillance systems capable of tracking influenza, COVID-19, respiratory syncytial virus and other respiratory pathogens simultaneously.

These systems are designed to enable earlier detection of outbreaks and support more timely public health responses.WHO officials also highlighted efforts to strengthen workforce capacity through regional training programmes in epidemiology, laboratory diagnostics and outbreak investigation.

These initiatives have supported the adoption of genomic surveillance techniques, allowing for more detailed analysis of circulating viruses and improving risk assessment capabilities.The organisation said that lessons learned during the COVID-19 pandemic informed the development of a regional operational strategy focused on community protection under the PIP framework.

This strategy is aligned with broader global mechanisms, including the International Health Regulations (2005) and WHO’s Health Emergency Preparedness and Response framework. It is intended to guide the use of funding, support evidence-based policymaking and improve resilience at the community level.Countries that have invested in influenza preparedness infrastructure have also been able to apply these systems to other respiratory threats.

WHO cited responses to Middle East respiratory syndrome (MERS), avian influenza and emerging pathogens as examples of how established surveillance and laboratory networks can be leveraged beyond their original scope.Investment priorities have evolved over time, moving from the establishment of basic surveillance systems to improvements in quality, integration and advanced capabilities such as genomic sequencing.

WHO said regional technical teams have played a role in strengthening virus characterisation and ensuring that data generated in the EMR contribute effectively to global decision-making processes.The framework has also supported countries in generating national-level evidence on disease burden and vaccine effectiveness. WHO noted that Iraq has formally adopted a national influenza vaccination policy, while Tunisia, Lebanon and Jordan are in the process of developing similar frameworks.

These policy developments reflect varying national priorities, with some countries focusing on innovation and system integration and others concentrating on maintaining essential services in fragile settings.WHO emphasised that tailored approaches remain critical given the diversity of conditions across the region. Targeted support, adapted to individual country contexts, is seen as key to strengthening health systems and ensuring continuity of surveillance and response activities.

Looking ahead, WHO said continued alignment with global strategies, including the Global Influenza Strategy and ongoing discussions around a Pandemic Agreement, will be necessary to sustain progress.

The organisation highlighted the importance of long-term investment and regional collaboration in maintaining preparedness gains and mitigating the risk of cross-border disease transmission.

In Japan, where life expectancy ranks among the highest globally, researchers and policymakers have long examined the cultural and social practices that contribute to longevity.

According to data from the World Health Organization, Japan’s average life expectancy exceeds 84 years, placing it consistently at the top of global rankings. Government statistics from the Ministry of Health, Labour and Welfare attribute this outcome to a combination of dietary patterns, healthcare access, and social structures that support ageing populations.

One focal point of research has been Okinawa, a southern prefecture often cited in longevity studies due to its high concentration of centenarians.

Academic studies conducted by institutions such as the National Institute of Health and Nutrition indicate that residents in Okinawa have historically maintained lower rates of cardiovascular disease and certain cancers compared to national averages, although these trends have begun to shift in recent decades.

Japanese dietary habits have been identified as a central factor in long life expectancy. Traditional meals emphasize fish, vegetables, soy-based products, and fermented foods, with relatively low consumption of red meat and processed items.

Researchers often cite the practice of “hara hachi bu,” a cultural guideline originating in Okinawa that encourages eating until one is approximately 80% full. Studies published by the Japanese government’s health agencies suggest that this approach contributes to lower caloric intake and reduced rates of obesity.

National data indicates that Japan’s obesity rate remains among the lowest in developed economies. According to the Ministry of Health, Labour and Welfare, adult obesity prevalence is below 5%, significantly lower than in many OECD countries.

Public health officials link this outcome not only to diet composition but also to portion control and meal structure, which typically includes multiple small dishes rather than a single large serving.Nutrition researchers at the National Institute of Health and Nutrition have also highlighted the role of fish consumption, which provides omega-3 fatty acids associated with cardiovascular health.

Fermented foods such as miso and natto are widely consumed and are believed to support gut health, although ongoing research continues to examine their long-term effects.

Beyond diet, social structures play a measurable role in Japan’s longevity profile. Studies examining ageing populations emphasize the importance of community engagement and social cohesion.

In Okinawa, the concept of “moai,” or informal social support groups, has been documented in academic literature as a mechanism for maintaining social ties throughout life. These groups often provide emotional support, financial assistance, and a sense of belonging, particularly among older residents.

Government data indicates that older adults in Japan remain more socially and physically active compared to counterparts in many other developed countries. According to surveys conducted by the Ministry of Health, Labour and Welfare, a significant proportion of individuals aged 65 and above participate in community activities, part-time work, or volunteer initiatives.

This sustained engagement is associated with lower levels of social isolation, a factor that global health studies have linked to increased mortality risk.Urban planning and infrastructure have also been cited as contributing factors.

Japanese cities are generally designed to encourage walking and public transport use, leading to higher baseline levels of physical activity. Researchers note that daily movement, rather than structured exercise alone, plays a role in maintaining health over time.

Japan’s universal healthcare system is another key component underpinning longevity. Established in the 1960s, the system ensures broad access to medical services at controlled costs.

According to the World Health Organization, Japan’s healthcare model combines public insurance with regulated pricing, enabling high levels of service utilization without proportionate increases in expenditure.Preventive care is emphasized through regular health check-ups, which are widely available and often subsidized.

Government data indicates high participation rates in screening programs for conditions such as hypertension and certain cancers. Early detection and management of chronic diseases are considered central to extending healthy life expectancy, a metric that Japanese policymakers track alongside overall lifespan.

Pharmaceutical regulation and dietary guidelines are also integrated into national health strategies. The Ministry of Health, Labour and Welfare periodically updates nutritional recommendations, reflecting evolving research on ageing and disease prevention. Public awareness campaigns reinforce these guidelines, contributing to relatively high levels of health literacy.

Despite these structural advantages, officials have acknowledged emerging challenges. Changes in dietary habits, particularly among younger populations, have been linked to rising rates of metabolic disorders in some regions.

In Okinawa, for instance, recent studies indicate a shift away from traditional diets toward higher consumption of processed foods, coinciding with increased obesity rates.

Japan’s experience has drawn sustained international attention, with policymakers and researchers examining how cultural practices intersect with formal healthcare systems to influence long-term outcomes.

The combination of dietary moderation, social integration, and accessible medical care continues to form the basis of the country’s longevity model, as reflected in both national statistics and global health assessments.

A growing body of research has linked exposure to per- and polyfluoroalkyl substances (PFAS) with adverse reproductive outcomes, including reduced sperm counts, prompting concern among residents in Bentham after blood tests revealed elevated levels of the chemicals. For some individuals, these findings have provided a possible explanation for longstanding health uncertainties.

One resident, Stephen, described the results as offering a form of clarity, saying they answered questions he had been grappling with regarding fertility issues.Scientific analysis of the Bentham blood samples has intensified scrutiny.

Dr David Megson, a forensic environmental scientist at Manchester Metropolitan University, compared the results with PFAS levels typically observed in the United States population and reported unusually high concentrations.

He stated that a majority of those tested exceeded average background levels, with approximately two-thirds falling within the highest five percent and a significant proportion surpassing levels normally recorded in population studies.

He characterized the findings as unexpected and markedly elevated relative to established benchmarks.Dr Shubhi Sharma, representing the environmental organization Chem Trust, described the detected PFAS concentrations as concerning, noting that existing research has associated these substances with a range of adverse health outcomes, including certain cancers.

However, the interpretation of such data remains contested within regulatory and industrial frameworks.Angus Fire, a manufacturer of firefighting foams with operations linked to the area, has disputed interpretations of the blood data.

A company spokesperson stated that there is no internationally standardized method for interpreting PFAS blood test results and emphasized the lack of consensus regarding the relationship between measured blood levels and specific health outcomes.

The company further argued that it is unfounded to characterize the Bentham results as unusually high within a UK context, pointing to the limited size of the tested group and cautioning against drawing definitive conclusions.

Residents have also raised concerns about environmental exposure pathways. Lindsay Young, who reported a PFAS level of 30 ng/ml, described routine fire testing activities at the Angus Fire site, stating that warning sirens often preceded the arrival of dense smoke in nearby residential areas.

She noted that the composition of the emissions was not disclosed to the community, contributing to uncertainty about potential health risks.In response, Angus Fire stated that it conducts routine fire tests as part of ensuring the effectiveness of firefighting products and maintained that such activities have been carried out responsibly.

The company added that it ceased testing PFAS-containing foams at the Bentham site in 2022 and asserted that historical operations at the facility were not the sole source of PFAS contamination in the surrounding environment.

An internal report by the Environment Agency in 2024 identified airborne emissions from foam testing as a potential pathway for PFAS exposure. The report indicated that aerial dispersal during testing could lead to contamination affecting both workers and nearby residents. It suggested that chemicals released into the air could settle over surrounding land, potentially entering soil and water systems and subsequently affecting locally grown produce.

Tony Fletcher, an epidemiologist at the London School of Hygiene and Tropical Medicine, noted that elevated PFAS levels among individuals with no direct occupational link to the factory pointed to community-wide exposure. He explained that airborne particles generated during foam testing could travel beyond the immediate site, eventually depositing onto land and entering food and water sources, thereby creating indirect exposure routes.

Regulatory oversight of these activities remains fragmented. The Environment Agency stated that fire testing was not covered under the site’s environmental permit, placing responsibility for regulation with local authorities. However, North Yorkshire council indicated that such testing activities were exempt from provisions of the Clean Air Act 1993 due to the company’s association with firefighting operations, which otherwise restrict emissions of dark smoke from commercial premises.

The issue of PFAS contamination extends beyond Bentham, with similar concerns emerging in other regions. Fletcher is part of a scientific advisory panel working with the Jersey government following contamination of private drinking water supplies linked to firefighting foam use at an airport.

The panel has recommended that individuals with elevated PFAS levels, particularly women of childbearing age and those above certain thresholds, may be considered for medical interventions.These include the use of colesevelam, a cholesterol-lowering medication shown in some cases to reduce PFAS concentrations in the body, as well as therapeutic blood removal as a secondary option.

Fletcher indicated that individuals in Bentham concerned about elevated PFAS levels could consult healthcare providers to explore these approaches, though such measures remain subject to clinical judgment.

Angus Fire acknowledged concerns related to historical operations and stated that it has been working with environmental consultants and regulatory authorities to assess the extent of contamination.

The company emphasized that its activities have adhered to existing regulatory guidelines and noted ongoing efforts to better understand the environmental impact of PFAS associated with its operations.

The absence of standardized international thresholds for PFAS exposure and the limited consensus on health implications continue to complicate regulatory and medical responses.

While emerging research has strengthened associations between PFAS and various health risks, officials and industry representatives maintain that further evidence is required to establish definitive causal relationships and to guide policy and enforcement frameworks.